Inspire Veterinary PARTNERS, Inc. (IVPR) intrinsic value & 10-year financials
Inspire Veterinary PARTNERS, Inc. (IVPR) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 4 fiscal years revenue grew 29.9% a year to $16.6M, with an average return on invested capital of 188.3%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.00
- Revenue (FY2024)
- $16.6M
- Revenue growth (4-yr CAGR)
- 29.9%
- ROIC (10-yr avg)
- 188.3%
- Free cash flow (FY2024)
- -$10.2M
IVPR 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2024 | $16.6M | -$14.3M | — | -$10.2M | -54.4% | -183.9% |
| FY2023 | $16.7M | -$14.8M | — | -$4.2M | -43.1% | 677.5% |
| FY2022 | $9.8M | -$4.9M | — | -$2.8M | -35.8% | 71.2% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
INSPIRE VETERINARY PARTNERS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
INSPIRE VETERINARY PARTNERS, INC. has earned high returns on invested capital, averaging 25.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
INSPIRE VETERINARY PARTNERS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, INSPIRE VETERINARY PARTNERS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment.